Commonly used diabetes and cardiovascular medications and cancer recurrence and cancer-specific mortality: A review of the literature

Keyphrases

• Comorbidity 100%
• Cancer Mortality 100%
• Cancer Recurrence 100%
• Cardiovascular Medications 100%
• Diabetes Medications 100%
• Cancer-specific Survival 66%
• Clinical Trials 33%
• Diabetes 33%
• Cancer Risk 33%
• Risk Reduction 33%
• Diagnosis Treatment 33%
• Aspirin 33%
• Statins 33%
• Beneficial Effects 33%
• Negative Effects 33%
• Metformin 33%
• Antihypertensive Medication 33%
• Cancer Outcomes 33%
• Expert Opinion 33%
• Confounding 33%
• Medication Use 33%
• Cancer Diagnosis 33%
• Anti-inflammatory Drugs 33%
• Evidence-based Decision Making 33%
• Area Cover 33%
• Cancer Prognosis 33%
• Misclassification 33%
• Medication Classes 33%
• Competing Risks 33%
• Precancer 33%
• Statin Drugs 33%
• Exposure Outcome 33%
• Informative Censoring 33%
• State of the Field 33%
• Methodological Shortcomings 33%

Pharmacology, Toxicology and Pharmaceutical Science

• Malignant Neoplasm 100%
• Cancer Recurrence 100%
• Observational Study 42%
• Comorbidity 42%
• Cancer Survival 28%
• Antihypertensive Agent 28%
• Hydroxymethylglutaryl Coenzyme A Reductase Inhibitor 28%
• Clinical Trial 14%
• Precancer 14%
• Acetylsalicylic Acid 14%
• Anti-Inflammatory Drug 14%
• Metformin 14%
• Cancer Prognosis 14%

Nursing and Health Professions

• Malignant Neoplasm 100%
• Cancer Recurrence 100%
• Comorbidity 50%
• Cancer Survival 33%
• Antihypertensive Agent 33%
• Hydroxymethylglutaryl Coenzyme A Reductase Inhibitor 33%
• Cancer Diagnosis 16%
• Metformin 16%
• Cancer Prognosis 16%
• Precancer 16%